Protease, Serine, 56

Alternative Names

  • PRSS56

Associated Diseases

Microphthalmia, Isolated 6
Back to search Result
OMIM Number

613858

NCBI Gene ID

646960

Uniprot ID

P0CW18

Length

5,329 bases

No. of Exons

12

No. of isoforms

1

Protein Name

Serine protease 56

Molecular Mass

64597 Da

Amino Acid Count

603

Genomic Location

chr2:232,520,388-232,525,716

Gene Map Locus
2q37.1

Description

This gene encodes a protein that contains a peptidase S1 domain and possesses trypsin-like serine protease activity. The encoded protein may play a role in eye development, and mutations in this gene are a cause of autosomal recessive posterior microphthalmos. [fFromRefSeq]

Molecular Genetics

Located on the long arm of chromosome 2, the PRSS56 gene spans a length of about 5 kb.  Its coding sequence is made up of 13 exons.  The protein encoded by the gene is made up of 603 amino acids and is approximately 64 kDa in size.  The protein is made up of three domains: an N terminal signal peptide, a central serine protease domain, and a C-terminal conserved domain.  

More than a dozen PRSS56 mutations, both homozygous and compound heterozygous, have been linked to microphthalmia, isolated 6.  Of these, truncating mutations have been shown to result in a more severe phenotype compared to missense mutations.

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
NM_001195129.2:c.1066dupLebanon; Saudi ArabiaNC_000002.12:g.232523825dupLikely Pathogenic, PathogenicLikely PathogenicMicrophthalmia, Isolated 6NG_031969.1:g.8363dup; NM_001195129.2:c.1066dup; NP_001182058.1:p.Gln356ProfsTer15273088206431077
NM_001195129.2:c.1555G>ASaudi ArabiaNC_000002.12:g.232525249G>APathogenicLikely PathogenicMicrophthalmia, Isolated 6NG_031969.1:g.9787G>A; NM_001195129.2:c.1555G>A; NP_001182058.1:p.Gly519Arg730882162183175
NM_001195129.2:c.1601T>GSaudi ArabiaNC_000002.12:g.232525295T>GLikely PathogenicMicrophthalmia, Isolated 6NG_031969.1:g.9833T>G; NM_001195129.2:c.1601T>G; NP_001182058.1:p.Val534Gly
NM_001195129.2:c.388T>GSaudi ArabiaNC_000002.12:g.232522102T>GNG_031969.1:g.6640T>G; NM_001195129.2:c.388T>G; NP_001182058.1:p.Cys130Gly

Other Reports

Saudi Arabia

Nowilaty et al. (2013) investigated the biometric and molecular characteristics of 24 posterior microphthalmos affected individuals.  A genetic analysis of the PRSS56 gene revealed mutations in 19 of the patients.  These included one known truncating mutation, and three novel missense mutations: c.1555G>A (p.G519R), c.3888T>G (p.C130G) and c.1691T>G (p.V534G).  The novel mutations were not found in 96 ethnically-matched controls. PolyPhen and SIFT analysis found these variants to be ‘probably damaging’ and ‘affecting protein function’.  The authors noted that there were no clinical differences between patients carrying MFRP mutations, PRSS56 mutations or no detected mutation. However, patients with the PRSS56 truncating mutation had shorter mean axial length compared to patients with PRSS56 missense mutations.  They also displayed higher mean corneal power, smaller mean corneal diameter, and higher mean hyperopia. 

© CAGS 2024. All rights reserved.